Cupid Limited is entering a joint venture to establish a condom manufacturing plant in South Africa, retaining a 49% stake. The local partner will fund all expansion and operating costs, adopting an asset-light model for the company. This comes after Cupid reported a 194% jump in quarterly profit to Rs 44.15 crore, highlighting strong growth in its international business.
Cupid Limited has secured board approval to establish a manufacturing joint venture in South Africa, a move aimed at deepening its presence in the African healthcare market. Under the agreement, the company will hold a 49% equity stake in the new entity, which will focus on producing, testing, and distributing male condoms and related products.
A key feature of this deal is its asset-light structure. While Cupid will contribute its technical and manufacturing expertise to the partnership, the local South African partner has agreed to fund 100% of the money spent on expansion, working capital, and day-to-day operating expenses. This arrangement allows the company to scale its production capacity and gain better access to regional government tenders without directly bearing the full financial burden of setting up the new plant.
This expansion plan follows a period of robust growth for the company. In its recently reported June quarter results for the current financial year, Cupid recorded a consolidated net profit of Rs 44.15 crore, a significant increase of 194% compared to the same period last year. Revenue also showed strong momentum, rising to Rs 154.72 crore, largely driven by demand in international business-to-business segments and success in private export markets.
While the expansion is a strategic step, investors should note the specific business risks involved. The success of this venture relies heavily on the operational execution capabilities of the local partner. Because the company will be operating as a minority partner, it has less direct control over daily site management. Furthermore, the company’s business model in this region often depends on institutional procurement programs, such as large government tenders. Any changes in South African local ownership requirements, manufacturing policies, or tender conditions could impact the long-term viability of the project. Additionally, as the company’s stock has seen significant appreciation, it trades at higher valuation multiples compared to its historical averages, which is a factor shareholders may monitor alongside future earnings growth.
The venture is expected to strengthen the company’s long-term revenue pipeline by positioning it closer to key export markets. Shareholders will get more details during the company’s 33rd Annual General Meeting, which is scheduled for September 22, 2026, and will be held via video conferencing.